4 Einträge gefunden

1. Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer

   1. Jacobsen, Frank
   2. Taskin, Billurvan
   3. Melling, Nathaniel
   4. Sauer, Charlotte
   5. Wittmer, Corinna
   6. Hube-Magg, Claudia
   7. Kluth, Martina

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
2. HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer

   1. Burdelski, Christoph
   2. Ruge, Oliver M
   3. Melling, Nathaniel
   4. Koop, Christina
   5. Simon, Ronald
   6. Steurer, Stefan
   7. Sauter, Guido

   2015 - Forschungsinformationssystem des UKE
3. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

   1. Melling, Nathaniel
   2. Thomsen, Erik
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Minner, Sarah
   7. Koop, Christina

   2015 - Forschungsinformationssystem des UKE
4. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

   1. Burdelski, Christoph
   2. Menan, Devi
   3. Tsourlakis, Maria Christina
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Melling, Nathaniel
   7. Minner, Sarah

   2015 - Forschungsinformationssystem des UKE - frei zugänglich